Pharmaceutical Business review

Columbia Laboratories names new board member

Mr Campbell is a manager and senior analyst for Dorset Management and a member of Knott Partners Management. Mr Campbell holds a BS degree from McGill University.

Mr Campbell is an independent director under the current NASDAQ national market listing standards and brings to seven the number of independent directors on the company’s eight-person board. Mr Campbell is expected to serve on the board’s audit committee and scientific committee.

Bob Mills, president and CEO of Columbia Laboratories, said: “Tony brings valuable experience in advising public companies in the life sciences industry and can contribute significantly to our company.”